Literature DB >> 6187080

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.

M Torisu, M Katano, Y Kimura, H Itoh, M Takesue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6187080

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  28 in total

1.  An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice.

Authors:  K Kino; K Mizumoto; T Sone; T Yamaji; J Watanabe; A Yamashita; K Yamaoka; K Shimizu; K Ko; H Tsunoo
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

2.  Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore.

Authors:  Esther W L Chuwa; Lay-Wai Khin; Weng-Hoong Chan; Hock-Soo Ong; Wai-Keong Wong
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

3.  Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.

Authors:  M Saito; O Ichimura; M Kataoka; Y Moriya; K Ueno; Y Sugawara; M Nanjo; N Ishida
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis.

Authors:  H Fukui; C W Reynolds; B Lenz; M Schneider; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer.

Authors:  M Torisu; Y Hayashi; T Ishimitsu; T Fujimura; K Iwasaki; M Katano; H Yamamoto; Y Kimura; M Takesue; M Kondo
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  The characterization of peritoneal and pleural exudate cells from malignant effusions.

Authors:  M Oka; S Yoshino; S Hazama; K Shimoda; T Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  OK-432-combined adoptive immunotherapy as a prognostic factor in peritoneal metastasis from gastric cancer.

Authors:  K Mise; N Kan; T Okino; Y Moriguchi; T Harada; Y Ichinose; K Inoue
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

8.  Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study.

Authors:  K Sugimachi; Y Maehara; K Akazawa; Y Kondo; Y Kunii; M Kitamura; H Yamaoka; Y Takahashi; T Kito; M Katou
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice.

Authors:  Y Moriya; H Sato; K Ito; M Saito; T Yoshida; N Ishida
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

10.  Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors.

Authors:  K D Yang; R M Stone; C S Lee; T Y Chao; S N Cheng; M F Shaio
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.